<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Urine NMR metabolomics (OPLS-DA) distinguishes pre-invasive colorectal neoplasia — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Urine NMR metabolomics (OPLS-DA)</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>pre-invasive colorectal neoplasia</strong>
</div>
<div class="entity-id">UNKNOWN:urine nmr metabolomics (opls-da) &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 21.04<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (Curated, 1 paper)<br>Score from 20 citations: <strong>21.04</strong><br><span style="color:#888">15&times; extends (+13.90) &middot; 3&times; supports (+6.44) &middot; 1&times; contradicts (+0.40) &middot; 1&times; applies (+0.30)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1038/s41598-019-41216-y">10.1038/s41598-019-41216-y</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 20 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:20px"></span><span>3</span><span class="cite-subtotal">&middot; +6.44</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">taurine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.64</span><a href="../claim/c46d79d6a72d684c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">taurine — decreases → colorectal cancer liver metastasis</span><span class="cite-claim-weight">+1.00</span><a href="../claim/085d425052ce8882.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Fusobacterium nucleatum — causes → colorectal cancer metastasis</span><span class="cite-claim-weight">+0.79</span><a href="../claim/a2a12040ef8be7d8.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:7px"></span><span>1</span><span class="cite-subtotal">&middot; +0.40</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Taurine — is_biomarker_for → Urachal adenocarcinoma</span><span class="cite-claim-weight">+0.40</span><a href="../claim/25a212842c3ae8cf.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>15</span><span class="cite-subtotal">&middot; +13.90</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Phosphatidylcholines (PCs) — is_biomarker_for → Colorectal Carcinoma</span><span class="cite-claim-weight">+4.80</span><a href="../claim/4d490d6332335a4a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Taurine — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/33e4ff3e124bfc3e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">MALDI-MSI metabolomics panel — distinguishes → Urachal adenocarcinoma vs Colorectal adenocarcinoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/1986b8533105aaaf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Taurine — distinguishes → Urachal adenocarcinoma vs Colorectal adenocarcinoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5b22657bbd09fcef.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">urinary metabolomics — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5d15112b1b6f12af.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bacteroides fragilis — causes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ac621f870de06af9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">gut microbiome metabolites — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ce0bb518dc1841de.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC 44:5 — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/30c5fd9ccfe505fb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC 35:6e — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8ddc19efefc1659b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SM d40:3 — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8e4961dd3a493b4d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipid panel (PC 44:5 + PC 35:6e + SM d40:3) — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/7c0a44eef9f07abe.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine — is_biomarker_for → colorectal advanced adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/735d077b4e121736.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelin — is_biomarker_for → colorectal advanced adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/4e8c3e1d7977e813.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelin — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/bdaabbf0139a1174.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">differential lipids (top 10) — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/d90eba95077dd648.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:7px"></span><span>1</span><span class="cite-subtotal">&middot; +0.30</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Colorectal cancer — causes → death</span><span class="cite-claim-weight">+0.30</span><a href="../claim/2210739709380dcd.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>5b8b10057594960d</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:urine nmr metabolomics (opls-da)">UNKNOWN:urine nmr metabolomics (opls-da)</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
